| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.076 | 0.6 |